Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024.
"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."
Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month.
The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses.
Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent.
Longtime CNN host Don Lemon is out at the cable news network a little over two months after apologizing to viewers for on-air comments about Republican presidential candidate Nikki Haley, CNN announced Monday.
The SAG-AFTRA National Board over the weekend voted unanimously to express solidarity with the Writers Guild of America and its plans to go on strike amid ongoing negotiations with studios and streamers.
Lila Snyder, CEO of Bose, joins Cheddar News anchor Hena Doba to discuss her journey to the top of the corporate world, the business of selling top of the line speakers, and how new technologies such as machine learning are shaking up the industry.
Stocks drifted ahead of reports that could offer clues on questions that have kept Wall Street at a standstill, including on where the economy and corporate profits are heading.
